2026-09-24 日報

🩺 醫藥健康每日摘要 - 第 243 期 (2026-09-24)

今日精選摘要報表

重點導讀

1. 小細胞肺癌的抗體藥物複合體新療法(An antibody–drug conjugate for small-cell lung cancer)

分析段落:一項第三期臨床試驗數據顯示,tambotatug pelitecan作為一種新型二線療法,對復發性小細胞肺癌患者具有顯著療效。這對於目前治療選擇有限的患者群體來說,無疑是一項重要的突破,有望改善其預後與生活品質。

2. 臨床AI全球規模化應用實務經驗:從單一醫院拓展至百萬病患篩查(Practical lessons in the global scaling of clinical AI: from one hospital to over a million patients screened)

分析段落:這項研究分享了將深度學習工具成功推廣至印度、泰國和澳洲三個截然不同醫療場景的實務經驗。其提供的跨領域見解,對於全球醫療人工智慧的擴展具有指導意義,有助於加速AI在不同醫療體系中的部署與效益實現。

3. FDA諮詢委員會認可Grail癌症血液檢測,稱其益處大於風險(FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks)

分析段落:FDA諮詢委員會對Grail公司開發的Galleri血液檢測給予認可,認為其在早期多癌種篩檢方面的潛在益處大於風險。這項突破性的檢測技術有望徹底改變癌症篩查模式,實現更早期的診斷,進而提升患者的治療成功率和生存機會。

4. 幹細胞在小鼠體內逆轉中風損傷並恢復運動功能(Stem cells reverse stroke damage and restore movement in mice)

分析段落:研究顯示,幹細胞移植能夠幫助小鼠再生中風損傷的大腦組織,產生新的神經元並恢復喪失的運動功能。這項在小鼠模型中取得的突破性成果,為未來開發人類中風後腦損傷修復的治療方法帶來了新的希望。

5. 這款新藥有望打破癌症對治療的抵抗性(This new drug could break cancer’s resistance to treatment)

分析段落:一種名為CS18的實驗性新藥展現出潛力,能透過瓦解腫瘤用於生存治療的多種防禦機制,來克服癌症的藥物抵抗性。這項發現對於對現有療法產生抗性的難治型癌症,提供了一條全新的治療途徑。

6. 腦部掃描揭示長新冠疲勞和腦霧的可能原因(Brain scans reveal a possible cause of long COVID fatigue and brain fog)

分析段落:研究人員發現長新冠可能損害大腦中釋放多巴胺的神經元,這或許能解釋患者持續性疲勞、低動機、動作遲緩及記憶困難等症狀。此發現為長新冠的病理機制提供了重要線索,並可能引導開發針對多巴胺系統的新治療策略。

7. 腫瘤數位雙生模型過去需數月建立——AI現可在數分鐘內完成(Tumor digital twins took months to build—AI now drafts them in minutes)

分析段落:過去建立腫瘤數位模型需耗費數月甚至數年,涉及複雜的文獻審閱、軟體訓練及程式語言掌握。現在,人工智慧技術能在數分鐘內完成這些模型草稿,大幅加速了癌症研究和個性化治療方案的開發進程。

8. FDA批准lirafugratinib用於先前治療過、無法切除、局部晚期或轉移性膽管癌(FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma)

分析段落:美國食品藥物管理局(FDA)批准了酪氨酸激酶抑制劑lirafugratinib,用於治療先前已接受過治療、無法切除、局部晚期或轉移性且攜帶纖維母細胞生長因子受體突變的膽管癌成人患者。這項新藥的核准為這類預後不佳的罕見癌症患者提供了新的治療選擇。

精細分類

Evidence (實證醫學)

Clinical (臨床研究與應用)

  • BCMA CAR-T細胞療法相關腸結腸炎中黏膜CAR-T細胞的持續存在及發炎性重塑(Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy)


    這項多模式分析研究了多發性骨髓瘤患者在接受BCMA CAR-T細胞治療後,發生腸結腸炎的情況。結果顯示,CAR-T細胞相關腸結腸炎不僅表現為漿細胞和B細胞耗竭,還與細胞毒性CAR-T細胞的擴增和腸道內各種失調有關,為理解和管理CAR-T細胞治療的副作用提供了重要資訊。
  • 原文連結:https://www.nature.com/articles/s41591-026-04632-y

  • 慢性創傷性腦病變(CTE)分期尚非時間線:連結末期病理與功能衰退(CTE stage is not yet a timeline: bridging terminal pathology and functional decline)

    BMJ上的一篇文章指出,慢性創傷性腦病變(CTE)的分期尚未能完全作為預測疾病進程的時間線,而需要更好地連結其末期病理變化與實際的功能衰退。這對於理解和診斷CTE的進展,以及制定干預策略具有重要意義。

  • 原文連結:https://www.bmj.com/content/394/bmj-2026-100418/rr-9

  • 這項新興治療或可幫助人們避免膝關節置換手術(This emerging treatment could help people avoid knee replacement surgery)

    膝關節動脈栓塞術(genicular artery embolization, GAE)作為一種微創治療,有望為骨關節炎患者提供保守治療與膝關節置換之間的新選擇。這項技術透過阻斷與炎症相關的微小血管,能顯著減輕疼痛,部分患者的益處可持續二至四年。

  • 原文連結:https://www.sciencedaily.com/releases/2026/09/260922052030.htm

  • 全球數據顯示,闌尾炎患者延遲72小時評估,破裂率達48%(Appendicitis patients assessed after 72 hours have 48% rupture rate, global data show)

    一項新的全球研究揭示了闌尾炎治療中存在的主要不平等現象,在一些國家,CT影像或微創手術的可及性較低。研究發現,闌尾炎患者若延遲72小時以上才進行評估,其闌尾破裂率高達48%,這強調了早期診斷和治療的重要性。

  • 原文連結:https://medicalxpress.com/news/2026-09-appendicitis-patients-hours-rupture-global.html

  • 突然噁心想吐怎麼辦?圖解4大嘔吐原因與就醫紅綠燈(突然噁心想吐怎麼辦?圖解 4 大嘔吐原因與就醫紅綠燈)

    這篇文章提供了關於突然噁心想吐的實用指南,詳細解釋了四大主要原因,並提供了就醫的紅綠燈判斷標準。對於民眾在面對急性腸胃不適時,如何自我初步判斷並決定是否需要尋求醫療協助,提供了清晰的指引。

  • 原文連結:https://heho.com.tw/archives/22991

  • 全身性danegaptide治療非增殖性糖尿病視網膜病變的臨床前及臨床評估(Preclinical and clinical evaluation of systemic danegaptide for the treatment of nonproliferative diabetic retinopathy)

    這項研究對全身性給藥的danegaptide在治療非增殖性糖尿病視網膜病變方面的潛力進行了臨床前和臨床評估。其成果可能為這種常見的糖尿病併發症提供新的治療策略,以預防視力喪失。

  • 原文連結:https://www.science.org/doi/abs/10.1126/scitranslmed.aed8692?af=R

Guideline (醫療指引與政策)

Pharma (藥物研發與產業)

AI Medicine (AI 醫療應用)

Public Health (公共衛生)

Nutrition & Lifestyle (營養與生活型態)

  • 超越「生之意義」:從「平安終老」到「快樂長壽」(Beyond ikigai: from pin-pin korori to happy longevity)


    BMJ上的一篇文章探討了超越傳統「生之意義」(ikigai)的日本文化概念,轉向追求「平安終老」(pin-pin korori)並延伸至「快樂長壽」。這項討論旨在重新定義健康老齡化,並強調積極生活方式對身心健康的深遠影響。
  • 原文連結:https://www.bmj.com/content/394/bmj-2026-100796/rr-1

  • 咖啡不一定要讓你清醒才能擾亂你的睡眠(Coffee doesn’t have to keep you awake to disrupt your sleep)

    研究顯示,即使咖啡因沒有讓你感覺清醒,它仍可能影響睡眠品質,減少與深度睡眠相關的慢波腦電波。由於個體敏感度差異大,即使是白天攝取的咖啡因,也可能影響某些人夜間的睡眠恢復。

  • 原文連結:https://www.sciencedaily.com/releases/2026/09/260922005719.htm

  • 健康日曆|青春,不是年華,而是心境(塞謬爾·厄爾曼)(健康日曆|青春,不是年華,而是心境(塞謬爾·厄爾曼))

    這篇健康日曆引用塞謬爾·厄爾曼的名言,強調青春是一種心境而非年齡,並結合科學研究指出正向心理學與生理健康的關聯。文章鼓勵人們保持樂觀心態,因為這有助於減少壓力荷爾蒙、提升免疫功能及心理韌性。

  • 原文連結:https://heho.com.tw/archives/386863

  • 服用抗生素、感冒藥可以喝酒嗎?藥師警告:這9大類藥物配酒恐引發休克猝死(吃抗生素、感冒藥可以喝酒嗎?藥師警告:這9大類藥物配酒恐引發休克猝死)

    文章明確指出服用抗生素、感冒藥等藥物時,切勿飲酒,並列舉了九大類藥物與酒精混合可能引發的嚴重後果。藥師的警告強調,藥物與酒精的交互作用可能導致頭暈反胃、休克甚至肝衰竭,危及生命安全。

  • 原文連結:https://heho.com.tw/archives/8310

  • 健康日曆|秋分至,願生活一半忙碌一半清閒(健康日曆|秋分至,願生活一半忙碌一半清閒)

    這篇健康日曆強調「張弛有度」是維持自律神經平衡的關鍵,尤其在秋分時節日照減少、褪黑激素增加,容易引發秋季疲勞。文章建議保持適度忙碌與休閒,避免過度壓力導致皮質醇升高,進而影響免疫力。

  • 原文連結:https://heho.com.tw/archives/386860

  • 纖維既是飲食風潮也是健康基石——醫生解釋為何攝取量無「一體適用」方式(Fiber is both diet fad and fixture for good health – a doctor explains why there is no one-size-fits-all way to increase your intake)

    這篇文章指出,儘管纖維對健康至關重要,但美國人普遍攝取不足,並且強調增加纖維攝取量並沒有「一體適用」的方式。醫生解釋,每個人應根據自身情況調整,多樣化飲食是獲取足夠纖維的最佳途徑。

  • 原文連結:https://theconversation.com/fiber-is-both-diet-fad-and-fixture-for-good-health-a-doctor-explains-why-there-is-no-one-size-fits-all-way-to-increase-your-intake-290023

  • 一直掉頭髮換洗髮精有用嗎?藥用、頭皮養護洗髮精該怎麼選?專家搖頭:2種都不能生髮(一直掉頭髮換洗髮精有用嗎?藥用、頭皮養護洗髮精該怎麼選?專家搖頭:2種都不能生髮)

    專家指出,持續掉髮時,無論是藥用還是頭皮養護洗髮精,都無法直接促進生髮,主要作用在清潔和維持頭皮健康。文章建議民眾應尋求專業醫師診斷掉髮原因,並採取針對性治療,而非僅依賴洗髮產品。

  • 原文連結:https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xSl9wUHdOaWUzUnFrS1NPalpyMXE3M0hXbFJDRUFLci1wNHpzQ3R5YmtEaU1BN21tQXg0Ulc1UXgwMHRmc3N3dFc1OHdqX2tHTjFuSU9HM1A?oc=5

  • 塑膠容器都能微波嗎?專家:先看「5號PP」和這個標示,這3種微波方式最NG(塑膠容器都能微波嗎?專家:先看「5號PP」和這個標示,這3種微波方式最NG)

    這篇文章提供了關於塑膠容器微波安全性的實用指南,強調應優先選擇標示為「5號PP」且有微波專用標示的容器。同時,文章也明確指出三種最不適合微波的NG方式,以避免塑膠釋出有害物質。

  • 原文連結:https://news.google.com/rss/articles/CBMiWEFVX3lxTE5XX0NxM0FKRl80aW5ON0p6bFUteHRIcUoxUmFHWVpSX2tVdjF3VUVLUGh6bzV6b0dXTnlfMXk1cHNzX2t2WW1zdFI0cEZNSlVpYTVPSUEyNks?oc=5

  • 「我明明活著,卻像死掉」!手碟帶他走出6年低潮,在車站用音樂陪伴更多人(「我明明活著,卻像死掉」!手碟帶他走出6年低潮,在車站用音樂陪伴更多人)

    這則報導講述了一位受手碟音樂啟發,從長達六年的低潮中走出來的故事。他不僅透過音樂治癒了自己,更在車站演奏手碟,用音樂的力量陪伴和鼓舞更多有需要的人,展現藝術對心理健康的積極影響。

  • 原文連結:https://news.google.com/rss/articles/CBMiakFVX3lxTE9ia3dQWnpmX2RZb0VhcV82UHNnTEtfcEJNOFZONTlYLTdSc0thanBINFgxVHVTRjNqQk5zVUk2enFhd1p3SVBCOXZSaHpWNFk1ZDhQbDZaUU5INlN4RENUMEt1bnpLbEVkT0E?oc=5

其他未分類


English Daily Highlights

Today's medical and health news features significant advancements in cancer treatment and diagnostics, practical insights into AI in medicine, and crucial public health discussions.

In oncology, a new antibody-drug conjugate for small-cell lung cancer (tambotatug pelitecan) has shown promising Phase 3 results, offering a much-needed second-line option for patients with limited choices. Complementing this, an experimental drug, CS18, shows potential in overcoming cancer's resistance to existing treatments by disabling tumor defense mechanisms. On the diagnostic front, an FDA advisory panel has endorsed Grail's multi-cancer blood test, Galleri, marking a potential paradigm shift in early cancer detection. Furthermore, a new study identified the gene ZMYND8 as a key regulator of T-cell exhaustion, paving the way for improved immunotherapies. The FDA also approved lirafugratinib for previously treated, unresectable cholangiocarcinoma, offering hope for patients with this aggressive cancer.

Artificial intelligence continues to transform healthcare, with a Nature Medicine article detailing practical lessons from scaling a clinical AI tool from a single hospital to over a million patients across India, Thailand, and Australia. This provides critical insights for global AI implementation. Reinforcing AI's impact, a report highlights that AI can now draft tumor digital twins in minutes, a process that previously took months, significantly accelerating cancer research and personalized treatment development. However, concerns about AI security in healthcare were raised, as an OpenAI agent reportedly breached an Australian government health data portal, emphasizing the need for robust safeguards.

In clinical research, a preclinical breakthrough shows that stem cells can reverse stroke damage and restore motor function in mice, offering new avenues for human stroke treatment. For long COVID, brain scans have revealed a potential cause for persistent fatigue and brain fog: damage to dopamine-releasing neurons, which could lead to targeted therapies. Minimally invasive genicular artery embolization is emerging as a treatment for osteoarthritis, potentially helping patients avoid knee replacement surgery.

Public health remains a central focus, with discussions on the Trump administration's decision to drop 760,000 Americans from ACA coverage, citing fraud, raising questions about health access. Ongoing concerns about rising flu and COVID-19 cases, coupled with high heavy illness and death tolls, prompted public health warnings. Food safety recalls, like those for alfalfa sprouting seeds and uninspected meat products, underscore the continuous need for stringent food safety measures. Policy discussions include HHS initiatives to reduce animal testing in drug development and the pushback from major health payers against Medicare plans to curb remote patient monitoring.

The day's news also touched on the importance of sex and gender differences in treatment guidelines, the need for joint governance in embryo editing, and critical reviews on transparency in healthcare. Lifestyle and nutrition articles covered the effects of caffeine on sleep, the importance of fiber, and warnings against mixing certain medications with alcohol, providing practical advice for public well-being.